Noema Pharma
4 known investors
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs. The company works with patients, caregivers, and healthcare professionals throughout discovery and clinical development.
Founders & leadership
IL
Ilise LombardoChief Executive Officer
VK
Volker KnappertzExecutive Vice President of Research & Development
MS
Michael SamarChief Financial Officer
RL
Rob LasserChief Medical Officer